U bent geen gezondheidszorgbeoefenaar? Bezoek onze publieke website.

Een mogelijke bijwerking melden

Menu

Close

0

User logged in

Overlay Text

www.gskpro.com/nl-be

voor gezondheidszorgbeoefenaars

Visit our Public site

Event Registration successful

You now have sucesfully register for the event and you can also access the latest updates, events and resources.

In case you would like to receive SMS-reminders for the event you have registered, please update your communication preferences here.

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy the public content on our website

Event Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

$previewUrl

Anoro Ellipta 20 mcg

has been lorem added to your basket

View Basket

Unit for Hours:H

Unit for Minutes: M

Filter redirection page URL: events.html

Login overlay needed?: true

Filter Tags:Product|Therapeutische domeinen

Filter Tags values when filtered by all Tags:Alle producten | Alle therapiën | Alle indicaties

OutofBox filter category name:Formaat

Filter Reset all button text:Reset alles

Filter Apply button text:Toepassen

Events registration success message: U bent geregistreerd

Events registration failure message: U bent niet geregistreerd

Events un-registration success message: U bent uitgeschreven

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Tag Requirements value: all

Show More Naivagation Values: 10|25|50

Previous Text label: Vorige

Next Text label: Volgende

Show Text label: Toon:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:$ciamTextareaNoCopyEmail

U klikt door naar een site van derden.

GSK aanvaardt betreffende het gebruik van websites in beheer door derden, inclusief hun inhoud, geen enkele verantwoordelijkheid.

Verder

Ga terug

Overzicht van de productkenmerken

BEXSERO: Help een brede populatie te beschermen¹

BEXSERO is geïndiceerd voor de actieve immunisatie van personen vanaf de leeftijd van 2 maanden en ouder tegen invasieve meningokokkenziekte veroorzaakt door Neisseria meningitidis groep B.¹

Meer info

Real World Evidence - Digital Flipbook

Impact en veiligheid bij gebruik van BEXSERO in real-word in verschillende settings en doelgroepen.^2,3

Ontdek het verhaal achter de gepubliceerde real-world studies met Bexsero via het interactieve Digital Flipbook.

Naar Digital Flipbook

Samen Tegen Meningitis

Sensibilisatiecampagne over meningitis door meningokokken

naar de website

Referenties:

BEXSERO Samenvatting van de productkenmerken GSK. https://www.e-compendium.be/nl/bijsluiters/wetenschappelijk/6356/3040
Deceuninck G, Lefebvre B, Tsang R, Betala-Belinga JF, De Serres G, De Wals P. Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch. Vaccine. 2019;37(31):4243–4245.
Ladhani SN, Andrews N, Parikh SR, et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N Engl J Med. 2020;382(4):309–317.

Bexsero is een handelsmerk van GlaxoSmithKline.

PM-BE-BEX-WCNT-210008 - Juni 2021

Neem contact op

Contacteer ons

©2023 - 2024 - 2025 GlaxoSmithKline group of companies. Alle rechten voorbehouden. GlaxoSmithKline Pharmaceuticals s.a./n.v. Avenue Fleming 20, 1300 Wavre Belgium - PM-BE-NA-WCNT-210011 - V 4.0 | November 2023